Clinical Trial

Injection Sclerotherapy With Bleomycin VS Doxycycline in Patients With Lymphatic Malformations

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated January 6, 2026 (before its estimated July 26, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a randomized clinical trial comparing the safety and effectiveness of injection sclerotherapy using bleomycin versus doxycycline in children under 12 years with lymphatic malformations. The study will assess reduction in lesion size, clinical improvement, and treatment-related complications over six months.
Trial Details
NCT Number NCT07320001
Lead Sponsor Basharat Hussain
Conditions Lymphatic Abnormality
Enrollment 92 participants
Start Date 2026-01-26
Primary Completion 2026-07-26 (estimated)
Study Completion 2026-09-26 (estimated)
Updated on ClinicalTrials.gov 2026-01-06